- Home
- BCG vs LUCD Comparison
BCG vs LUCD Comparison
Compare BCG & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- LUCD
- Stock Information
- Founded
- BCG 2016
- LUCD 2018
- Country
- BCG United States
- LUCD United States
- Employees
- BCG N/A
- LUCD N/A
- Industry
- BCG
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BCG
- LUCD Health Care
- Exchange
- BCG Nasdaq
- LUCD Nasdaq
- Market Cap
- BCG 48.1M
- LUCD 49.0M
- IPO Year
- BCG N/A
- LUCD 2021
- Fundamental
- Price
- BCG $2.55
- LUCD $0.84
- Analyst Decision
- BCG
- LUCD Strong Buy
- Analyst Count
- BCG 0
- LUCD 4
- Target Price
- BCG N/A
- LUCD $3.63
- AVG Volume (30 Days)
- BCG 542.2K
- LUCD 277.7K
- Earning Date
- BCG 02-26-2025
- LUCD 11-13-2024
- Dividend Yield
- BCG N/A
- LUCD N/A
- EPS Growth
- BCG N/A
- LUCD N/A
- EPS
- BCG N/A
- LUCD N/A
- Revenue
- BCG $161,721,000.00
- LUCD $4,189,000.00
- Revenue This Year
- BCG N/A
- LUCD $91.72
- Revenue Next Year
- BCG N/A
- LUCD $139.38
- P/E Ratio
- BCG N/A
- LUCD N/A
- Revenue Growth
- BCG N/A
- LUCD 179.27
- 52 Week Low
- BCG $1.85
- LUCD $0.63
- 52 Week High
- BCG $16.61
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- BCG N/A
- LUCD 51.29
- Support Level
- BCG N/A
- LUCD $0.80
- Resistance Level
- BCG N/A
- LUCD $0.88
- Average True Range (ATR)
- BCG 0.00
- LUCD 0.05
- MACD
- BCG 0.00
- LUCD 0.01
- Stochastic Oscillator
- BCG 0.00
- LUCD 55.57
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.